BTMD
BTMD
NASDAQ · Pharmaceuticals

Biote Corp -A

$1.36
+0.01 (+0.74%)
As of Sep 20, 10:46 PM ET ·
Financial Highlights (FY 2026)
Revenue
180.27M
Net Income
25.36M
Gross Margin
71.5%
Profit Margin
14.1%
Rev Growth
+5.2%
D/E Ratio
9.02
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 71.5% 71.5% 32.3% 32.3%
Operating Margin 18.5% 16.6% 17.4% 19.3%
Profit Margin 14.1% 13.4% 14.6% 19.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 180.27M 171.33M 22.38M 21.94M
Gross Profit 128.82M 122.43M 7.24M 7.09M
Operating Income 33.35M 28.53M 3.89M 4.25M
Net Income 25.36M 21.70M 3.27M 4.37M
Gross Margin 71.5% 71.5% 32.3% 32.3%
Operating Margin 18.5% 16.6% 17.4% 19.3%
Profit Margin 14.1% 13.4% 14.6% 19.9%
Rev Growth +5.2% +5.2% -5.1% +24.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 21.67M 21.67M 11.22M 12.91M
Total Equity 2.40M 2.40M 63.17M 61.05M
D/E Ratio 9.02 9.02 0.18 0.21
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 35.22M 31.80M 5.70M 5.36M
Free Cash Flow 2.62M 2.18M